Extra Strength Hawthorn Extract 600 mg

Extra Strength Hawthorn Extract 600 mg

NOW4.8 (2,579 ratings)
Format:Capsule Quantity: 90 Capsule(s) · 90 servings
Goals

Product analysis

76 out of 100

Extra Strength Hawthorn Extract 600 mg offers a low-cost, single-herb option for people considering heart support. The preparation cannot be assumed equivalent to the particular extracts behind the limited heart-related findings.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality40

The named hawthorn marker helps identify the extract description. Comparative preparation quality remains uncertain, so it should not be equated with a particular clinical extract.

Ingredient Transparency100

The amount and extract description are stated, making basic comparisons easier. There is no mixed active blend obscuring its identity.

Value For Money100

The labeled serving cost compares favorably. That affordability is separate from whether the extract matches a preparation with supported benefits.

Customer Satisfaction87

Customer ratings are very positive across a large body of feedback. They describe satisfaction rather than establishing health benefits.

Product Focus73

A single herb keeps the purpose centered on heart-related support. The findings for particular extracts and clinical settings do not establish routine benefits from generic hawthorn.

Format
Capsule
Container
90 Capsule(s)
Per serving
$0.18
Customer rating
4.8 · 2,579 ratings
Report analysis

Goals

Impact
Highest effect
A+ Ingredient FitC- PathwaysB+ EvidenceA+ Formulation Logic
Hawthorn · 600 mg

Hawthorn’s cardiovascular research mainly concerns specific extracts used in treated heart failure. A large trial did not improve its primary cardiac-event outcome, and generic hawthorn cannot inherit the tested extract’s findings. The declared amount therefore does not establish routine cardiovascular benefit or identify the studied preparation.

How this product is rated for Cardiovascular Support

Ingredient fit97

Hawthorn is the focused ingredient, but generic material does not establish the extract used in heart-failure research. The supplied amount comparison is fully met.
Goal fit
Hawthorn provides a focused connection to the selected cardiovascular aspects.
Dose adequacy
The counted serving amount reaches the supplied exposure reference, without establishing a proven effective daily dose.

Pathways55

The strongest supplied connection is vascular tone and sodium balance. These assigned mechanisms concern selected markers, rather than proven cardiovascular-event prevention.
Depth
The strongest connection is vascular tone and sodium balance, reflecting declared amounts and assigned ingredient roles.
Breadth
One mechanism reaches the supplied coverage threshold, leaving the connection focused.

Evidence81

The supplied hawthorn finding does not establish generic-product benefit. Specific extract studies in treated heart failure do not transfer directly to this serving.
Evidence strength
Generic hawthorn does not establish the benefit of specific extracts tested in treated heart failure.
Studied preparation
The supplied preparation criterion is met, but generic hawthorn does not establish WS 1442 identity or equivalent effects.

Formulation logic100

No unmet partner requirement or specified formulation conflict was identified. Clearing the exposure threshold does not establish a clinically effective cardiovascular dose.
Partner coverage
The counted ingredients work without an additional required partner or have that partner present.
Conflicts
No specified formulation conflict was matched in the supplied product facts.
Effective doses
All counted ingredients clear the minimum exposure threshold, without establishing a clinically effective cardiovascular dose.
Study evidence
Hawthorn Supportive 28 studies
Heart Health
Impact
High effect
A+ Ingredient FitD- PathwaysC+ EvidenceA+ Formulation Logic

Hawthorn has been studied mainly as specific standardized extracts in clinical heart failure, with conflicting findings. Those results do not establish benefit for this ordinary hawthorn preparation or routine cardiovascular prevention. Its declared amount was recognized in the saved findings, but amount alone cannot resolve the difference in preparation and population.

How this product is rated for Heart Health

Ingredient fit97

Hawthorn provides the main recognized connection. The declared amounts meet the saved exposure comparison; this does not establish an effective daily regimen.
Goal fit
Hawthorn is the main recognized focus.
Dose adequacy
The declared amounts meet the saved exposure comparison; this does not establish an effective daily regimen.

Pathways41

The findings center on blood-vessel function, with narrow coverage across the evaluated functions.
Depth
The main recognized connection is blood-vessel function. The biological assignment does not establish benefit for this preparation.
Breadth
The breadth finding centers on blood-vessel function, rather than broad coverage of different heart-health functions.

Evidence66

Hawthorn was recognized in the saved evidence findings, but preparation-specific clinical findings do not establish routine benefit.
Evidence strength
Hawthorn was recognized in the saved evidence findings, but preparation-specific clinical findings do not establish routine benefit.
Studied preparation
The saved preparation check was met, but clinical extract evidence does not establish equivalence or routine benefit for this hawthorn.

Formulation logic100

Hawthorn has no identified required-partner gap or configured conflict. All ingredients counted for this check meet its minimum exposure criterion; that criterion is not proof of clinical benefit.
Partner coverage
No missing required partner was identified among the counted ingredients; this does not establish added benefit from combining them.
Conflicts
No configured ingredient conflict was identified in the supplied facts.
Effective doses
All ingredients counted for this check meet its minimum exposure criterion; that criterion is not proof of clinical benefit.
Study evidence
Hawthorn Supportive 27 studies

Ingredients

IngredientAmount per servingScore
Hawthorn extract (Vitexin-2”-O-Rhamnoside)
600 mg 71
Gluten Free Adults 18–50 Vegan Dairy Free Vegetarian
Report overview
C- Composition And Label DisclosureA+ Commercial Price And Usability
The serving lists 600 mg of hawthorn leaf and flower extract. A marker concentration and preparation ratio are not established in the saved facts, limiting more detailed comparisons.
How this ingredient is rated

Composition and Label Disclosure57

The serving lists 600 mg of hawthorn leaf and flower extract. No marker concentration or preparation ratio is established in the saved facts. A hawthorn species is indicated, though its name is not provided in the saved facts.
Marker and Preparation Disclosure
The saved facts name hawthorn leaf and flower extract, but do not establish a marker percentage or preparation ratio.
Species Name Disclosure
A hawthorn species is indicated, though its name is not provided in the saved facts.

Composition and Label Disclosure

No separate dose or safety rules were evaluated.

Commercial Price and Usability100

The price is about $0.18 per whole-product serving, which is relatively low.
Commercial Price per Labeled Serving
A whole-product serving costs about $0.18; that price is relatively low in the comparison.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Real world effectiveness of Hawthorn special extract WS 1442 in a retrospective cohort study from Germany.
    Wyss C; Gündling PW; Kostev K · Scientific reports · 2024
    Cohort study9,100 participantsCardiovascular Support forHawthorn
  2. Hawthorn (Crataegus spp.) Clinically Significantly Reduces Blood Pressure in Hypertension: A Meta-Analysis of Randomized Placebo-Controlled Clinical Trials.
    Szikora Z; Mátyus RO; Szabó BV; Csupor D; Tóth B · Pharmaceuticals (Basel, Switzerland) · 2025
    Meta-analysis428 participants6 studies pooledCardiovascular Support Heart Health forHawthorn
  3. A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
    Degenring FH; Suter A; Weber M; Saller R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2003
    Randomized trial143 participantsCardiovascular Support forHawthorn
  4. [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)].
    Weikl A; Assmus KD; Neukum-Schmidt A; Schmitz J; Zapfe G; Noh HS; Siegrist J · Fortschritte der Medizin · 1996
    Randomized trial136 participantsCardiovascular Support forHawthorn
  5. Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
    Habs M · Forschende Komplementarmedizin und klassische Naturheilkunde = Research in complementary and natural classical medicine · 2005
    Cohort study952 participantsCardiovascular Support forHawthorn
  6. [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
    Rietbrock N; Hamel M; Hempel B; Mitrovic V; Schmidt T; Wolf GK · Arzneimittel-Forschung · 2001
    Randomized trial88 participantsHeart Health forHawthorn
  7. Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.
    Pittler MH; Schmidt K; Ernst E · The American journal of medicine · 2003
    Meta-analysis632 participants13 studies pooledHeart Health forHawthorn
  8. Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II.
    Zapfe jun G · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2002
    Randomized trial40 participantsHeart Health forHawthorn
  9. Baseline severity but not gender modulates quantified Crataegus extract effects in early heart failure--a pooled analysis of clinical trials.
    Eggeling T; Regitz-Zagrosek V; Zimmermann A; Burkart M · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Meta-analysis687 participants10 studies pooledHeart Health forHawthorn